New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
09:24 EDTEPOC, ATHN, NSM, BAC, VVUS, ILMN, SQNM, RHHBYOn The Fly: Pre-market Movers
HIGHER: Epocrates (EPOC), up 22.6% after agreeing to be acquired by athenahealth (ATHN) for $11.75 per share, in cash... VIVUS (VVUS), up 9.6% after reporting strong growth in Qsymia prescriptions shipped to patients in December... Nationstar Mortgage Holdings (NSM), up 18.6% after confirming deal to acquire about $215B in mortgage servicing assets from Bank of America (BAC). Shares of BofA also up 0.7%... LOWER: Illumina (ILMN), down 9% after acquiring Verinata Health for $350M, Roche's (RHHBY) chairman reportedly says his company no longer looking to acquire Illumina... Sequenom's (SQNM), down 6.5% after reporting preliminary 2012 revenue, which William Blair says may be overshadowed by Illumina's acquisition of Verinata.
News For EPOC;ATHN;NSM;BAC;VVUS;ILMN;SQNM;RHHBY From The Last 14 Days
Check below for free stories on EPOC;ATHN;NSM;BAC;VVUS;ILMN;SQNM;RHHBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 19, 2014
06:20 EDTBACBofA COO transfers, senior manager assumes role, Bloomberg says
Subscribe for More Information
August 18, 2014
06:47 EDTBACU.S. banks consider Ireland fitting spot for EU divisions, FT says
Subscribe for More Information
August 17, 2014
13:40 EDTRHHBYChugai makes statement denying media reports on Roche deal
Subscribe for More Information
August 15, 2014
11:28 EDTRHHBYRoche in talks on $10B deal to buy remainder of Chugai, Bloomberg reports
Roche is in talks to purchase the 38% stake of Chugai Pharmaceutical that it doesn't already own, according to Bloomberg, citing people familiar with the matter. The potential deal is valued at approximately $10B. Though no financial decision has been made, the deal may be announced as early as next week, the sources added. Reference Link
11:02 EDTRHHBYRoche in talk on $10B deal to buy remainder of Chugai, Bloomberg says
Subscribe for More Information
10:07 EDTBACBank of America reports July default rate 3.01% vs. 3.24% last month
Subscribe for More Information
06:12 EDTRHHBYGilead announced favorable ruling in arbitration against Roche
Gilead (GILD) announced that an arbitration panel determined that Roche (RHHBY) failed to establish any of their claims and ruled in favor of Gilead. As a result, Roche is not entitled to any damages or other relief. In March 2013, Roche initiated an arbitration against Gilead and Pharmasset, predecessor to Gilead Pharmasset, regarding a 2004 collaboration agreement between Roche and Pharmasset. In the arbitration demand, Roche asserted that it had an exclusive license to sofosbuvir pursuant to the collaboration agreement because sofosbuvir, a prodrug of a uridine monophosphate analog, is allegedly a prodrug of PSI-6130, a cytidine analog. Roche further claimed that, because it had exclusive rights to sofosbuvir, it also had an exclusive license to a patent covering sofosbuvir, and that we infringed that patent by selling and offering for sale products containing sofosbuvir.
August 14, 2014
16:02 EDTRHHBYFDA approves Genentech’s Avastin plus chemotherapy for cervical cancer treatment
Subscribe for More Information
12:46 EDTNSMHayman Capital gives quarterly update on stakes
Subscribe for More Information
09:11 EDTRHHBYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Kohl's (KSS), up 2.5%... Plug Power (PLUG), up 10%... Perrigo (PRGO), up 4.5%. HIGHER: Aruba Networks (ARUN), up 3% after shares upgraded at Stifel... KaloBios (KBIO), up 7.9% after publication shows EphA3 as target for anticancer therapy... Supernus (SUPN), up 4.4% after receiving FDA fast track designation for SPN-810. DOWN AFTER EARNINGS: Noodles & Company (NDLS), down 22%... Vipshop (VIPS), down 5.8%. LOWER: ExOne (XONE), down 10.7%, Voxeljet (VJET), down 6.6%, after earnings reports. Peers in the 3D space are lower as well, with Stratasys (SSYS) down 1% and 3D Systems (DDD) down 0.2%... Enphase Energy (ENPH), down 2.6% after filing to sell common stock for holders... InterMune (ITMN), down 3% after downgraded at Goldman following yesterday's advance on Bloomberg report that the company received takeover bids from Sanofi (SNY), Roche (RHHBY).
08:28 EDTBACBofA, DOJ still in talks over $17B settlement, NY Post says
Subscribe for More Information
August 13, 2014
16:19 EDTRHHBYOn The Fly: Closing Wrap
Subscribe for More Information
13:13 EDTRHHBYInterMune exploring sale after bids from Sanofi, Roche, Glaxo, Bloomberg says
InterMune (ITMN) is working with its financial advisers Goldman Sachs (GS) and Centerview Partners to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF), said Bloomberg, citing people with knowledge of the matter. The report noted that one of the sources said Sanofi has so far shown the most interest in a deal for InterMune, whose shares are up more than 13% to $51.56 following the first headlines from the report. Reference Link
13:00 EDTRHHBYInterMune received takeover bids from Sanofi, Roche, Bloomberg says
August 12, 2014
10:00 EDTILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:35 EDTBACActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
07:48 EDTBACBanks posted second-highest profit in 23 years in second quarter, WSJ says
Subscribe for More Information
August 11, 2014
18:07 EDTILMNIllumina initiated with a Buy at Stifel
Target $200.
06:57 EDTATHNAvondale to hold a conference
Subscribe for More Information
05:53 EDTRHHBYCuris shares look attractive, says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use